About Metaphore
Metaphore is a company based in Cambridge (United States) founded in 2021 by Lovisa Afzelius and Daniel Acker. Metaphore has raised $50 million across 2 funding rounds from investors including Flagship Pioneering and TOHO HOLDINGS. Metaphore offers products and services including MIMIC Platform. Metaphore operates in a competitive market with competitors including Asimov, Cellarity, Panakeia, Evolved By Nature and Algorithmic Biologics, among others.
- Headquarter Cambridge, United States
- Founders Lovisa Afzelius, Daniel Acker
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$50 M (USD)
in 2 rounds
-
Latest Funding Round
Not available
-
Investors
Flagship Pioneering
& 1 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Metaphore
Metaphore offers a comprehensive portfolio of products and services, including MIMIC Platform.
Uses machine learning and molecular mimicry for therapeutic insights and drug development.
People of Metaphore
Unlock access to complete
Funding Insights of Metaphore
Metaphore has successfully raised a total of $50M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Metaphore
Metaphore has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Flagship Pioneering and TOHO HOLDINGS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life sciences-focused venture capital firm
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Metaphore
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Metaphore
Investment portfolio details for Metaphore
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Metaphore
Detailed financials for Metaphore
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Metaphore Comparisons
Peer comparison for Metaphore
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Metaphore
Metaphore operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Asimov, Cellarity, Panakeia, Evolved By Nature and Algorithmic Biologics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of integrated suite for advanced genetic design and manufacturing
|
|
| Locked | Locked | Locked |
Developer of drugs to treat various diseases
|
|
| Locked | Locked | Locked |
AI-based software is provided for cancer diagnosis and precision treatment.
|
|
| Locked | Locked | Locked |
Digital technology for biomedicinal molecule development in research is utilized.
|
|
| Locked | Locked | Locked |
Provider of software solutions for molecular diagnostics and discovery
|
Detailed competitors of Metaphore
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Metaphore
Complete news archive for Metaphore
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Metaphore
Metaphore was founded in 2021 and raised its 1st funding round 2 years after it was founded.
Metaphore is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Lovisa Afzelius is the current CEO of Metaphore. They have also founded this company.
Metaphore is a funded company, having raised a total of $50M across 2 funding rounds to date.
Provider of machine language and computational platform for drug discovery. The company uses biomimicry and machine learning to unleash the transformational medicinal potential of functional molecular mimics. The MIMiC platform, developed by the company is a computationally driven bioplatform for developing novel therapies in which function, specificity, and selectivity may be optimized.
Metaphore offers MIMIC Platform.
Metaphore has 2 investors. Key investors include Flagship Pioneering, and TOHO HOLDINGS.